167 related articles for article (PubMed ID: 27060366)
1. Characterization of a novel high-dose ovalbumin-induced murine model of allergic sinonasal inflammation.
Mendiola M; Tharakan A; Chen M; Asempa T; Lane AP; Ramanathan M
Int Forum Allergy Rhinol; 2016 Sep; 6(9):964-72. PubMed ID: 27060366
[TBL] [Abstract][Full Text] [Related]
2. Development of Aspergillus protease with ovalbumin-induced allergic chronic rhinosinusitis model in the mouse.
Kim JH; Yi JS; Gong CH; Jang YJ
Am J Rhinol Allergy; 2014; 28(6):465-70. PubMed ID: 25514482
[TBL] [Abstract][Full Text] [Related]
3. Natural Killer Cell Deficits Aggravate Allergic Rhinosinusitis in a Murine Model.
Kim JH; Gong CH; Choi GE; Kim SA; Kim HS; Jang YJ
ORL J Otorhinolaryngol Relat Spec; 2016; 78(4):199-207. PubMed ID: 27383429
[TBL] [Abstract][Full Text] [Related]
4. Development and immunopathological characteristics of an Alternaria-induced chronic rhinosinusitis mouse model.
Shin SH; Ye MK; Lee DW; Chae MH; Choi SY
PLoS One; 2020; 15(6):e0234731. PubMed ID: 32544181
[TBL] [Abstract][Full Text] [Related]
5. Rhinovirus infection in murine chronic allergic rhinosinusitis model.
Lee SB; Song JA; Choi GE; Kim HS; Jang YJ
Int Forum Allergy Rhinol; 2016 Nov; 6(11):1131-1138. PubMed ID: 27348296
[TBL] [Abstract][Full Text] [Related]
6. Development of a mouse model of eosinophilic chronic rhinosinusitis with nasal polyp by nasal instillation of an Aspergillus protease and ovalbumin.
Kim HC; Lim JY; Kim S; Kim JH; Jang YJ
Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3899-3906. PubMed ID: 28828551
[TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome.
Li HT; Zhang TT; Chen ZG; Ye J; Liu H; Zou XL; Wang YH; Yang HL
Int Immunopharmacol; 2015 Sep; 28(1):390-8. PubMed ID: 26163938
[TBL] [Abstract][Full Text] [Related]
8. Activation of STAT6 by intranasal allergens correlated with the development of eosinophilic chronic rhinosinusitis in a mouse model.
Wei H; Xu L; Sun P; Xing H; Zhu Z; Liu J
Int J Immunopathol Pharmacol; 2022; 36():3946320221109529. PubMed ID: 35726645
[TBL] [Abstract][Full Text] [Related]
9. Histological and immunological observations of bacterial and allergic chronic rhinosinusitis in the mouse.
Wang H; Lu X; Cao PP; Chu Y; Long XB; Zhang XH; You XJ; Cui YH; Liu Z
Am J Rhinol; 2008; 22(4):343-8. PubMed ID: 18702895
[TBL] [Abstract][Full Text] [Related]
10. Effect of genetic background on the response to bacterial sinusitis in mice.
Kirtsreesakul V; Luxameechanporn T; Klemens JJ; Thompson K; Naclerio RM
Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1102-8. PubMed ID: 17043259
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensis.
KuoLee R; Zhou H; Harris G; Zhao X; Qiu H; Patel GB; Chen W
Clin Exp Allergy; 2008 Jun; 38(6):1003-15. PubMed ID: 18307525
[TBL] [Abstract][Full Text] [Related]
12. The Comparation of Intraperitoneal Injection and Nasal-only Delivery Allergic Rhinitis Model Challenged With Different Allergen Concentration.
Wang Y; Zhou Y; Zhu Y; Yu W; Wang J; Fu J; Yuan Y; Yu Z; Chen S; Wang Y; Chen J; Kong W
Am J Rhinol Allergy; 2019 Mar; 33(2):145-152. PubMed ID: 30871345
[TBL] [Abstract][Full Text] [Related]
13. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of intranasal cyclosporine for eosinophilic rhinosinusitis with nasal polyps in a mouse model.
Chang DY; Joo YH; Kim SJ; Kim JH; Jung MH; Kim DW; Jeon SY; Kim SW
Am J Rhinol Allergy; 2015; 29(1):e29-32. PubMed ID: 25590314
[TBL] [Abstract][Full Text] [Related]
15. Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides.
Hussain I; Jain VV; Kitagaki K; Businga TR; O'Shaughnessy P; Kline JN
Laryngoscope; 2002 Oct; 112(10):1819-26. PubMed ID: 12368622
[TBL] [Abstract][Full Text] [Related]
16. Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B.
Hellings PW; Hens G; Meyts I; Bullens D; Vanoirbeek J; Gevaert P; Jorissen M; Ceuppens JL; Bachert C
Clin Exp Allergy; 2006 Aug; 36(8):1063-71. PubMed ID: 16911362
[TBL] [Abstract][Full Text] [Related]
17. Mast Cell Deficiency Limits the Development of Chronic Rhinosinusitis in Mice.
Hua X; Naselsky WC; Jania CM; Chason KD; Huang JJ; Doerschuk CM; Graham SM; Senior BA; Tilley SL
Ann Otol Rhinol Laryngol; 2016 Apr; 125(4):290-6. PubMed ID: 26681624
[TBL] [Abstract][Full Text] [Related]
18. Synergism of Staphylococcus aureus colonization and allergic reaction in the nasal cavity in mice.
Hohchi N; Hashida K; Ohkubo J; Wakasugi T; Mori T; Nguyen KH; Kuroda E; Ikeno T; Taniguchi H; Suzuki H
Int Arch Allergy Immunol; 2012; 159(1):33-40. PubMed ID: 22555155
[TBL] [Abstract][Full Text] [Related]
19. A synthetic glycosaminoglycan reduces sinonasal inflammation in a murine model of chronic rhinosinusitis.
Alt JA; Lee WY; Davis BM; Savage JR; Kennedy TP; Prestwich GD; Pulsipher A
PLoS One; 2018; 13(9):e0204709. PubMed ID: 30252910
[TBL] [Abstract][Full Text] [Related]
20. Murine model for chronic rhinosinusitis: an interventional study.
Hamour AF; Lee JJ; Wasilewski E; Monteiro E; Lee JM; Vescan A; Kotra LP
J Otolaryngol Head Neck Surg; 2023 Apr; 52(1):32. PubMed ID: 37098626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
